Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | MGLL | Q99685 | 5/20 | 0.48 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.48 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.48 |
| ▸ | FAAH | O00519 | 3/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | GAA | P10253 | 3/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | GSK3A | P49840 | 1/20 | 0.42 |
| ▸ | GSK3B | P49841 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5275664 | 0.98 | MAPT (0.56) | MAPTMGLLPTGS1PTGS2FAAH | |
| SCHEMBL9068830 | 0.92 | MAPT (0.58) | MAPTALDH1A1GAAMEN1KMT2A | |
| SCHEMBL6073396 | 0.84 | MAPT (0.61) | MAPTALDH1A1GAAMEN1KMT2A | |
| SCHEMBL16274020 | 0.82 | MEN1 (0.65) | MAPTMGLLPTGS1PTGS2FAAH | |
| SCHEMBL19220386 | 0.82 | MEN1 (0.65) | MAPTMGLLPTGS1PTGS2FAAH | |
| SCHEMBL26286 | 0.82 | MEN1 (0.65) | MAPTMGLLPTGS1PTGS2FAAH | |
| SCHEMBL14850663 | 0.82 | MEN1 (0.65) | MAPTMGLLPTGS1PTGS2FAAH | |
| SCHEMBL20176213 | 0.82 | MEN1 (0.65) | MAPTMGLLPTGS1PTGS2FAAH | |
| SCHEMBL28886326 | 0.82 | MEN1 (0.65) | MAPTMGLLPTGS1PTGS2FAAH | |
| SCHEMBL6597634 | 0.81 | MAPT (0.50) | MAPTALDH1A1GAAMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180144877-A1 | PHOTOELECTRIC CONVERSION ELEMENT, SOLAR CELL, AND COMPOUND | FUJIFILM CORPORATION (JP) | 2018-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180144877-A1 | PHOTOELECTRIC CONVERSION ELEMENT, SOLAR CELL, AND COMPOUND | SLC9A1, SLC9A2, SLC26A3 | MAPT 1251/4885MGLL 3994/4885PTGS1 3885/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.